Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mead Over

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos Medicine|July 18, 2012
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directionsGesine Meyer-Rath, Mead Over
Plos One|August 13, 2013
A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortalityMatthew Fox, Owen McCarthy, Mead Over
Health Policy (Amsterdam, Netherlands)|December 1, 2018
The economic returns of ending the AIDS epidemic as a public health threatErik Lamontagne, Mead Over, John Stover
Health Affairs (Project Hope)|March 9, 2006
Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?Ramanan Laxminarayan, Mead Over, David L Smith
AIDS Care|March 11, 2017
Mutual HIV status disclosure is associated with consistent condom use in public sector ART clients in Free State province, South Africa: a short reportFrederik le Roux Booysen, Edwin Wouters, Damien de Walque, et al.
The American Journal of Tropical Medicine and Hygiene|August 28, 2004
Impregnated nets or ddt residual spraying? Field effectiveness of malaria prevention techniques in solomon islands, 1993-1999Mead Over, Bernard Bakote'e, Raman Velayudhan, et al.
AIDS (London, England)|September 25, 2007
The economics of effective AIDS treatment in ThailandMead Over, Ana Revenga, Emiko Masaki, et al.
Plos Medicine|October 26, 2018
Epidemiological metrics and benchmarks for a transition in the HIV epidemicPeter D Ghys, Brian G Williams, Mead Over, et al.
Plos One|January 4, 2013
Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in ZambiaElliot Marseille, Mark J Giganti, Albert Mwango, et al.
Health Services Research|November 17, 2004
Assessing the efficiency of HIV prevention around the world: methods of the PANCEA projectElliot Marseille, Lalit Dandona, Joseph Saba, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos Medicine|July 18, 2012
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directionsGesine Meyer-Rath, Mead Over
Plos One|August 13, 2013
A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortalityMatthew Fox, Owen McCarthy, Mead Over
Health Policy (Amsterdam, Netherlands)|December 1, 2018
The economic returns of ending the AIDS epidemic as a public health threatErik Lamontagne, Mead Over, John Stover
Health Affairs (Project Hope)|March 9, 2006
Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?Ramanan Laxminarayan, Mead Over, David L Smith
AIDS Care|March 11, 2017
Mutual HIV status disclosure is associated with consistent condom use in public sector ART clients in Free State province, South Africa: a short reportFrederik le Roux Booysen, Edwin Wouters, Damien de Walque, et al.
The American Journal of Tropical Medicine and Hygiene|August 28, 2004
Impregnated nets or ddt residual spraying? Field effectiveness of malaria prevention techniques in solomon islands, 1993-1999Mead Over, Bernard Bakote'e, Raman Velayudhan, et al.
AIDS (London, England)|September 25, 2007
The economics of effective AIDS treatment in ThailandMead Over, Ana Revenga, Emiko Masaki, et al.
Plos Medicine|October 26, 2018
Epidemiological metrics and benchmarks for a transition in the HIV epidemicPeter D Ghys, Brian G Williams, Mead Over, et al.
Plos One|January 4, 2013
Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in ZambiaElliot Marseille, Mark J Giganti, Albert Mwango, et al.
Health Services Research|November 17, 2004
Assessing the efficiency of HIV prevention around the world: methods of the PANCEA projectElliot Marseille, Lalit Dandona, Joseph Saba, et al.
Pageof 2